https://www.bloomberg.com/news/articles/2023-01-23/apple-reality-pro-details-eye-hand-tracking-app-store-3d-ios-like-interface?sref=TBDibEcD
Mizuho Maintains Buy on BioXcel Therapeutics, Lowers Price Target to $18
Mizuho analyst Graig Suvannavejh maintains BioXcel Therapeutics (NASDAQ:BTAI) with a Buy and lowers the price target from $19 to $18.